Evidence map›Paper›PMID 32665670›Full record

ArticleScientific reports2020

Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.

Zihan Zhou, Xianguo Zhou, Yanji Jiang, Moqin Qiu, Xiumei Liang, Qiuling Lin, Qian Guo, Cunli Nong, Rongrui Huo, Qian Chen and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Molecular and genetic markers in hepatocellular carcinoma:World journal of gastrointestinal pathophysiology · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Zihan Zhou *Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xianguo Zhou *Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yanji JiangGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Moqin QiuGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xiumei LiangGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qiuling LinGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qian GuoDepartment of Infectious Disease, Liuzhou Workers' Hospital, Liuzhou, Guangxi, China.
Cunli NongDepartment of Infectious Disease, Liuzhou Workers' Hospital, Liuzhou, Guangxi, China.
Rongrui HuoGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qian ChenGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Haizhou LiuGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yingchun LiuGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Shaoliang ZhuGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China. slzhu2014@163.com.
Mengyun WangFudan University Shanghai Cancer Center, Shanghai, China. wangmengyun1120@163.com.
Hongping YuGuangxi Medical University Cancer Hospital, Nanning, Guangxi, China. yhp268@163.com.
Guangxi Medical University · CNFourth Affiliated Hospital of Guangxi Medical University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs play an indispensable role in human carcinogenesis. Dysregulated miR-1180-3p has been observed in several types of cancer, including hepatocellular carcinoma (HCC). This study intends to correlate the expression level of miR-1180-3p with clinical features and overall survival in HCC patients. The expression and clinical significance of miR-1180-3p, selected from GEO and TCGA databases, were verified using an RT-qPCR method. The target genes of miR-1180-3p were obtained using 3 miRNA target gene prediction databases, and their functions were analyzed using the online tool WebGestalt. miR-1180-3p expression was significantly upregulated in 88 HCC tissues compared with non-tumor liver tissues (0.004 ± 0.009 vs. 0.002 ± 0.002, t = - 2.099, P = 0.038). Additionally, we found that the expression levels of miR-1180-3p were significantly correlated with tumor number (χ

Indexed as

Computational BiologyBiomarkers, TumorCarcinoma, HepatocellularDisease-Free SurvivalFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateLiver NeoplasmsMaleMicroRNAsMiddle AgedBiomarkers, TumorMicroRNAsMIRN1180 microRNA, human

Identifiers

PMID32665670
PMCPMC7360737
OpenAlexW3043496734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.